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Abstract
Background: Ethics committees and their system of research protocol peer-review are currently
used worldwide. To ensure an international standard for research ethics and safety, however, data
is needed on the quality and function of each nation's ethics committees. The purpose of this study
was to describe the characteristics and developments of ethics committees established at medical
schools and general hospitals in Japan.
Methods: This study consisted of four national surveys sent twice over a period of eight years to
two separate samples. The first target was the ethics committees of all 80 medical schools and the
second target was all general hospitals with over 300 beds in Japan (n = 1457 in 1996 and n = 1491
in 2002). Instruments contained four sections: (1) committee structure, (2) frequency of annual
meetings, (3) committee function, and (4) existence of a set of guidelines for the refusal of blood
transfusion by Jehovah's Witnesses.
Results:  Committee structure was overall interdisciplinary. Frequency of annual meetings
increased significantly for both medical school and hospital ethics committees over the eight years.
The primary activities for medical school and hospital ethics committees were research protocol
reviews and policy making. Results also showed a significant increase in the use of ethical guidelines,
particularly those related to the refusal of blood transfusion by Jehovah's Witnesses, among both
medical school and hospital ethics committees.
Conclusion: Overall findings indicated a greater recognized degree of responsibilities and an
increase in workload for Japanese ethics committees.
Background
Ethics committees (EC) and the system of research proto-
col peer-review began in the United States (US) [1,2]. The
Declaration of Helsinki requires that all biomedical
research involving human participants, including research
on identifiable human material or data, should be
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approved by an ethical review committee [3,4]. Today,
ECs and their systems of peer-review for research protocol
are used worldwide [5-16].
Nowadays ECs in many countries review and consider
ethical issues pertaining to clinical care and institutional
policy. In fact, clinical ECs often function independently
from research ethics committees [17,18]. For instance, in
the United Kingdom (UK), clinical ECs largely function
for ethics support and advice for healthcare providers [17-
20]. In the US, institutional or hospital ECs (HECs) carry
out ethics consultation and other clinically relevant activ-
ities [1].
Japanese ECs differ in system, however, from those in the
US and UK. The first medical school in Japan to establish
an EC was Tokushima University School of Medicine in
1982. Ten years later, in 1992, all 80 medical schools in
Japan had voluntarily established an EC without any gov-
ernmental regulation. This same trend emerged among
general hospitals as well. The percentage of hospitals with
o v e r  3 0 0  b e d s  t h a t  m a i n t a i n e d  a n  E C  i n c r e a s e d  f r o m
24.6% in 1996 to 52.0% in 2002 according to the Minis-
try of Health, Labour and Welfare [21,22].
In Japan, the term for ethics committees (rinri-iinkai) is
often translated as an IRB, but this is quite misleading. At
medical schools and the majority of general hospitals,
there are actually two types of ECs [23]: an EC that reviews
and monitors drug clinical trials called a chiken-shinsa-
iinkai (clinical trial review committee), and an EC that
reviews protocols from researchers affiliated with the
institution called a rinri-iinkai (ethics committee). Clinical
trial review committees are regulated by the Ministry of
Health, Labor and Welfare and function in accordance
with the Pharmaceutical Law and the Guidelines for Good
Clinical Practice (GCP)[23]. Accordingly, their structure
and management are strictly regulated. Hospitals and uni-
versities involved with clinical trials for commercial prod-
ucts (i.e., pharmaceuticals) are thus required by the GCP
to maintain a clinical trial review committee. Conversely,
ECs not involved with clinical trials for commercial prod-
ucts are primarily self-governing bodies established by
each institution and are not government regulated. In gen-
eral, medical school ECs are more involved with research
protocol review than their counterpart in hospitals; they
also play a larger role as a leader in policy making when
compared to hospital ECs.
Today, concerns over the quality and function of ECs are
increasing worldwide. Numerous studies have examined
the activities and quality of ethical review of ECs among
Westernized countries included Australia, Belgium, Can-
ada, Israel, Italy, France, Germany, Netherlands, New Zea-
land, Spain, Sweden, Switzerland, the UK and the US [5-
8,11-14,16-18]. Many of these studies have provided
descriptive data on EC functions and structure [9-12,16].
Yet, despite the wealth of literature from Westernized
countries, there persists a limited amount of research from
Asia [10,15]. The purpose of this survey study was to
describe the characteristics and developments of ECs
established at medical schools and general hospitals in
Japan. In general, medical school and hospital ECs are
combined ethics committees taking on the roles of both
clinical and research ethics committees. Japanese ECs are
regulated independently by each facility as opposed to the
British system in which ECs are established based on area
(LREC: local research ethics committee), and accredited
according to the rules formulated by the UK Ethics Com-
mittee Authority [24]. We excluded clinical trial review
committees from our sample given their differences in
structure, function and regulations when compared to reg-
ular ECs. This study included four national surveys con-
ducted twice over a period of eight years.
Methods
The study consisted of four national surveys sent to two
separate samples. The first target was the ECs of all 80
medical schools and the second target was all general hos-
pitals with over 300 beds in Japan. In July 1995 and
August 2002, we mailed a self-administered instrument to
the EC at all 80 medical schools. By 1995, all Japanese
medical schools had established an EC. Concurrently, we
mailed a self-administered instrument addressed to the
Chief of Staff at all general hospitals with over 300 beds in
April 1996 (n = 1457) and March 2002 (n = 1491). This
sample of general hospitals did not include university
hospitals.
Instrument
Each instrument contained four sections: (1) committee
structure; (2) frequency of annual meetings; (3) commit-
tee function; (4) existence of ethical guidelines for the
refusal of blood transfusion by Jehovah's Witnesses. We
chose to use number four because the existence of ethical
guidelines for dealing with Jehovah's Witnesses in Japan
can serve as a possible indicator of EC functionality. Two
additional sections were included in instruments devel-
oped for medical school ECs that pertained to awareness
of the binding power of committee decisions and aware-
ness of recent changes in responsibility.
Analysis
All data were edited and analyzed using SPSS Windows
Version 11.0 to determine frequency of responses for each
category. To measure the strength of association between
variables, tests of significance, such as the t test and Chi
Squared test, were calculated.BMC Medical Ethics 2007, 8:8 http://www.biomedcentral.com/1472-6939/8/8
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Ethical considerations
The study was approved by the University of Tokyo Grad-
uate School of Medicine Research Ethics Committee. All
instruments were mailed with a letter explaining the
objectives of the study, protection of personal informa-
tion, and how all responses were voluntary.
Results
From medical schools, 80 instruments were returned in
1995 (response rate 100%) and 62 were returned in 2002
(response rate 77.5%). From hospitals, 743 instruments
were returned in 1996 (response rate 51.0%) and 464
instruments were returned in 2002 (response rate 31.1%).
The results of the 1996 survey of general hospital ECs were
partly presented previously in Japanese [25].
Respondent attributes (table 1) and ratio of established 
ECs (table 2)
Table 1 and Table 2 report the attributes of the respond-
ents. In 1995, all medical schools (n = 80) had an estab-
lished ECs. Conversely, only 181 (24.4%) of general
hospitals in this study responded that they had estab-
lished an EC in 1996[15] (result from reference 15),
which increased significantly to 270 (58.2%) by 2002
(Figure 1: Number of Ethics Committees Established at
General Hospitals in Japan).
Structure of ethics committees at medical schools (table 3) 
and hospitals (table 4)
Table 3 and Table 4 each report the structure of ECs at
responding institutions. All data was collected during the
initial surveys. The overall ratio of male to female com-
mittee members was 94:6 among medical school ECs and
87:13 among hospital ECs. Medical school ECs consisted
of an average of more than one member from outside of
the medical school, yet within the same college/univer-
sity, as well as from altogether outside of the college/uni-
versity. Hospital ECs also consisted of an average of more
than one member who was unaffiliated with the facility.
In general, the discipline of EC members varied. Medical
doctors and healthcare professionals comprised the
majority, but medical school ECs included approximately
one legal adviser. Professionals of ethics and other
humanities were also included.
Process of ethics committees
Findings indicated an increase in workload among ECs.
Medical school ECs met an average of 3.6 (SD:3.6) times
in the year prior to the survey in 1995 and 7.7 (SD:4.6)
times in the year prior to the survey in 2002. Hospital ECs
met an average of 2.4 (SD:3.2) times in the year prior to
the survey in 1996 and 3.1 (SD: 3.3) times in the year
prior to the survey in 2002. In both cases, the frequency of
meetings per year showed a significant increase (p < 0.01).
Number of cases discussed per year for medical school
ECs increased significantly from 5.7 (SD:5.7) cases in
1995 to 51.2 (SD:52.0) cases in 2002 (p < 0.01).
Activities of ethics committees at medical schools (table 5) 
and hospitals (table 6)
The activities of medical school and hospital ethics com-
mittees are reported in Tables 5 and 6. Answers were mul-
tiple-choice. An average of 85.0% of medical school ECs
responded that their everyday activities consisted of
reviews of protocols for patient-targeted clinical research,
regardless of whether they were related to medical treat-
ment. Over 80% of medical school ECs were also involved
in policy making, defined here as the establishing of regu-
lations and guidelines for a certain treatment or research
subject. Conversely, hospital ECs were primarily involved
in the ethical review of protocols for patient-targeted clin-
ical research directly related to medical treatment
(70.6%). Compared to medical school ECs, fewer hospital
ECs were involved in the review of protocols for patient-
targeted clinical research unrelated to medical treatment
(28.9%). Hospital ECs were also considerably involved in
policy making (55.5%). A comparison of medical school
and hospital ECs found that medical school ECs were
more involved in the issuing of certificates intended for
the editorial board of an academic journal than hospital
ECs (33.8%:10.6%), and that hospitals ECs were more
involved in ethics consultation (17.5%:32.2%).
Use of ethical guidelines
Instruments included a question on whether ECs had
implemented an ethical guideline on the refusal of blood
transfusion based on religious reasons (Jehovah's Wit-
nesses). Among medical schools ECs in 1995, 31 (38.8%)
responded yes to this question; 29 (36.3%) replied no; 13
(16.3%) responded that they were still considering it; five
(6.3%) replied other and two (2.5%) did not reply. Con-
versely, in 2002, 35 (56.5%) medical schools replied yes
to this question; 16 (25.8%) replied no; six (9.7%) replied
that they were still considering it; three (4.8%) replied
other and two (3.2%) did not reply. A significant increase
was found in the use of an ethical guideline among med-
ical school ECs (χ2 = 4.6, p < 0.05). Again, among hospi-
tals ECs, 142 (19.1%) in 1996 replied yes to this question;
533 (71.7%) replied no; 57 (7.7%) replied that they were
still considering it and 11 (1.5%) did not reply (result
from reference 22). Conversely, in 2002, 159 (34.3%)
replied yes; 265 (57.1%) replied no; 23 (5.0%) replied
that they were still considering it and 17 (3.7%) did not
reply. A significant increase was found in the use of an eth-
ical guideline among hospital ECs (χ2 = 35.5, p < 0.01).
Awareness of binding power and legal liability
Instruments targeted to medical school ECs included a
question on how much binding power and legal liability
they considered their decisions to carry. A total of 51BMC Medical Ethics 2007, 8:8 http://www.biomedcentral.com/1472-6939/8/8
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Table 1: Respondents to the medical school survey
1995 2002
N = 80 % N = 62 %
Sex
Male 80 100 60 96.8
Female 0 0.0 2 3.2
Age
3 0 ' s 22 . 500 . 0
4 0 ' s 56 . 346 . 5
50's 15 18.8 17 27.4
60's 54 67.5 40 64.5
7 0 ' s 11 . 311 . 6
NA 3 3.8 0 0.0
Committee Position
Committee chair 67 83.8 52 83.8
Committee co-chair 3 3.8 4 6.5
Member 3 3.8 6 9.7
Other 5 6.3 0 0.0
NA 2 2.5 0 0.0
University Type
National University 32 40 25 40.3
National College 19 23.8 15 24.2
Private University 11 13.8 5 8.1
Private College 18 22.5 17 27.4
Table 2: Respondents to the general hospital survey
1996 2002
N = 743 % N = 464 %
Sex
Male 624 84.0 418 90.1
Female 7 0.9 0 0.0
NA 112 15.1 46 9.9
Age
2 0 ' s 00 . 010 . 2
30's 17 2.3 3 0.6
40's 85 11.4 44 9.5
5 0 ' s 2 5 53 4 . 31 5 63 3 . 6
6 0 ' s 3 2 54 3 . 72 3 35 0 . 2
70's 37 5.0 12 2.6
NA 24 3.2 15 3.2
Hospital Position
Chief of Staff 536 72.1 364 78.4
Co-chief of Staff 110 14.8 57 12.3
Physician 46 6.2 23 5.0
Administrator 23 3.1 10 2.2
Other 6 0.8 2 0.4
NA 22 3.0 8 1.7
Hospital Type
National 97 13.1 46 9.9
Public 326 43.9 270 58.1
P r i v a t e 2 6 53 5 . 71 4 03 0 . 2
Other 35 4.7 0 0.0
NA 20 2.7 8 1.7BMC Medical Ethics 2007, 8:8 http://www.biomedcentral.com/1472-6939/8/8
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(63.8%) ECs in 1995 compared to 20 (32.3%) in 2002
believed that, "Since decisions are mere advice and have
no binding power, ECs cannot take disciplinary action
and have no legal liability." Seventeen (21.3%) ECs in
1995 compared to 28 (45.2%) in 2002 believed that,
"Although decisions carry binding power and ECs can
take disciplinary action, it is the university or university
hospital, not the EC itself, that has legal liability." Three
(3.8%) ECs in 1995 compared to 7 (11.3%) in 2002
believed that, "Since decisions carry binding power and
ECs can take disciplinary action, the EC has legal co-liabil-
ity with the university or university hospital." Nine
(11.3%) ECs in 1995 and 7 (11.3%) in 2002 answered
"don't know or other." These results show a significant
increase in awareness of decision binding power and legal
liability among medical school ECs (χ2 = 15.8, p < 0.01).
Recent trends
Instruments targeted to medical school ECs in 2002 also
included a question on whether the topic of reviews had
diversified in recent years. Forty (64.5%) ECs replied
"much more diversified" and 19 (30.6%) answered
"slightly more diversified." Only 2 (3.2%) replied "no
change"; 1 (1.6%) answered "slightly less diversified,"
and none replied "much less diversified." In regards to an
additional question that asked whether responsibilities
have increased in recent years, 40 (64.5%) ECs replied
"much more" and 18 (29.0%) answered "slightly more."
Four (6.5%) ECs replied "no change" and none answered
"much less" or "slightly less."
Discussion
The goal of this study was to gain an overview of the char-
acteristics and developments of ECs established at medi-
cal schools and general hospitals in Japan with a series of
four national surveys conducted over a period of eight
years. The descriptive results intimate a gradual growth in
number of ECs, an increase in frequency of annual meet-
ings and number of reviews, an increase in the use of eth-
ical guidelines, and a greater recognized degree of
responsibilities for Japanese ECs.
According to reports by the Ministry of Health, Welfare
and Labor, the number of ECs (rinri-iinkai) in general hos-
pitals with over 300 beds increased from 24.6% in 1996
to 52.0% in 2002 [21,22]. One possible factor related to
this increase in number of ECs among general hospitals in
Japan is the recent introduction of a system of evaluation
[26]. In fact, it was in 1998 when the Japan Council for
Quality Healthcare (JCQH), a non-governmental agency
that evaluates hospitals, added the category of EC in their
evaluation instrument. Again, yet another factor related to
this increase is the recent succession of governmental eth-
ical guidelines. Around the turn of the century, a series of
statutory guidelines, in all seven guidelines, strongly "rec-
ommended" that institutions establish an EC [23]. For
instance, the Ethical Guideline for Human Genome and
Gene Analysis Research and the Ethical Guideline for Epi-
demiological Research mandated that all related-research
need to undergo EC review. Accordingly, this change in
policy may also have had an impact on the increase of ECs
and on their increase in responsibility and number of
reviews. This study was carried out before and after the
addition of the evaluative category of ECs by the JCQH in
1998, as well as before and after the succession of govern-
mental ethical guidelines around 2000. Study findings
thus reflect the impact of these events.
The system of ECs in Japan has two unique and notewor-
thy characteristics: (1) medical schools and the majority
of hospitals have established their EC voluntarily without
any governmental regulation, and (2) ECs play the roles
of both IRB and HEC, as defined in the US. Now even
though medical schools and hospitals voluntarily set up
their EC, their structure is largely similar. They all include
members who are external, of both sexes, and from other
fields than medicine. This standardization may largely be
The Number of Ethics Committees Established at General  Hospitals in Japan Figure 1
The Number of Ethics Committees Established at General 
Hospitals in Japan. *Data were obtained from 2002 hospital 
survey.
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a product of the Liaison Society for Ethics Committees of
Medical Schools [27], an association set up in 1988
among all medical school ECs to exchange information
and communicate. Presently, the association meets two
times a year to discuss relevant issues to the further devel-
opment and needs of ECs. To our knowledge, no other
nation has such an association that functions as a national
alliance of medical school ECs. Incidentally, another fac-
tor related to the apparent homogeneity in structure
among ECs may be the succession of ethical guidelines
issued by the government around the turn of the century.
A second significant characteristic of ECs in Japan is that
they are not only involved with review of research proto-
cols, like IRBs in the US, but are also in charge of policy
making, education, and consultation, similar to HEC in
the US context. The reason for this double-role playing
among Japanese ECs is because the GCP originally
assigned all drug clinical trials to clinical trial review com-
mittees (chiken-shinsa-iinkai), and left the remaining
responsibilities to ECs (rinri-iinkai). Today, the primary
role for medical school and hospital ECs is research pro-
tocol review and policy making.
Study findings also showed a significant increase in the
use of ethical guidelines among both medical school and
hospital ECs. However, we also found a difference
between medical school and hospital ECs. In 1995–6,
38.5% of medical school ECs compared to 19.1% of hos-
pital ECs used an ethical guideline for blood transfusion
by Jehovah's Witnesses. Again this difference was seen in
2002 with 56.5% of medical schools ECs using an ethical
guideline compared to 34.3% of hospital ECs. We surmise
that this difference is because medical school ECs tend to
be more active than hospital ECs in developing policy.
One possible explanation for this disparity is that medical
school ECs generally function as a leader in developing
ethical policy in Japan. Looking deeper, this may be
Table 3: Characteristics of ethics committees
Medical School
Characteristics Mean ± SD Range
Total members 10.4 ± 2.6 6–22
External members (outside of medical school but within same college/university) 1.3 ± 1.3 0–6
External members (outside of same college/university) 1.4 ± 1.1 0–5
Female members 0.6 ± 0.9 0–6
Discipline of EC members
Basic medicine 2.7 ± 1.1 1–8
Clinical medicine 4.0 ± 1.6 1–8
Other medicine 0.7 ± 1.1 0–4
Nursing 0.3 ± 0.6 0–3
Other healthcare field 0.1 ± 0.4 0–3
Law 1.0 ± 0.6 0–3
Philosophy/Ethics 0.5 ± 0.6 0–3
Other Humanities and/or Social Sciences 0.4 ± 0.7 0–3
Administrative 0.2 ± 0.6 0–4
Other 0.5 ± 0.9 0–4
Table 4: Characteristics of ethics committees
General Hospital
Characteristics Mean ± SD Range
Total members 10.3 ± 4.9 4–27
External members 1.2 ± 1.4 0–8
Female members 1.3 ± 1.3 0–8
Discipline
Chief of staff 0.7 ± 0.04 0–1
Co-chief of staff 1.4 ± 0.9 0–4
Physician 4.1 ± 4.3 0–18
Nurse 1.2 ± 1.0 0–7
Co-medical staff 0.5 ± 0.9 0–5
Administrator 0.5 ± 1.0 0–4
Attorney/Consultant 0.4 ± 0.6 0–3
Philosopher/Ethicist 0.3 ± 0.6 0–4
Other 0.4 ± 0.9 0–6BMC Medical Ethics 2007, 8:8 http://www.biomedcentral.com/1472-6939/8/8
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related to the hierarchy of Japan's medical world in which
universities hold the mainstay of power.
Overall findings showed a greater degree of responsibili-
ties and an increase workload for Japanese ECs. The vast
majority of ECs indicated that their responsibilities have
increased "much more" in recent years. This is related to
several factors: ECs having to function both as IRB and
HEC, the rush of ethical guidelines, and an overall rise in
social awareness regarding bioethical issues [28]. Whether
a standard of quality is being maintained among Japanese
ECs given the increase in workload and responsibilities is
a topic of future study and discussion. To ensure a consist-
ent standard of quality of review and function among ECs
in Japan, researchers and policy makers need to consider
the possibilities of a central IRB, the introduction of a sys-
tem of registration for ECs, increased legal binding power
for committee decisions and the further development of
ethics consultation.
Limitations
This study is subject to several limitations. First, the
response rate among general hospitals was low, yet since
the ratio of established hospital ECs in this study was sim-
ilar to that officially reported by the Ministry of Health,
Labor and Welfare, this study's sample is thought to be
representative. Second, we cannot determine whether
nonrespondents would have answered questions differ-
ently. Third, we surveyed only one member of each insti-
tution, whose assessments and judgments may differ from
those of the committee as a whole. Fourth, the use of an
ethical guideline for dealing with Jehovah's Witnesses
may not serve as a valid index for adequate functioning of
a committee. Further research is needed in order to
develop a scale to assess the efficacy of functioning of a
committee. Lastly, respondents will at best provide
approximate answers to activity distributions and the like.
Although these responses are subject to errors of recall
and estimation, they are adequate in providing a current
view of ECs in Japan.
Conclusion
Ethics committees play an essential role in research and
healthcare by aiming to ensure the safety of patients and
research participants. While the system of ECs in Japan
was largely imported from the West, its history of develop-
ment and systems of management are unique. Ethics com-
mittees and the system of research protocol peer-review
continue to spread worldwide among nations that differ
in culture, healthcare system and governmental structure.
This is a positive trend, yet to better ensure a common
international standard among all nations worldwide, fur-
ther data and research are needed on each nation's system
of EC.
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Table 5: Activities at medical school ECs 1995 (n = 80)
(%)
Review of clinical research related to treatment with patients as subjects 74(92.5)
Review of clinical research unrelated to treatment with patients as 
subjects
62(77.5)
Review of clinical research with non-patients as subjects 58(72.5)
Review of basic research with animals as subjects 16(20.0)
Issuing of a committee approval certificate for the editorial board of an 
academic journal
27(33.8)
Policy-making 66(82.5)
Consultation 14(17.5)
Education 17(21.3)
Table 6: Activities at hospital ECs 1996 (n = 180)
(%)
Review of clinical research related to treatment with patients as subjects 127(70.6)
Review of clinical research unrelated to treatment with patients as 
subjects
52(28.9)
Review of clinical research with non-patients as subjects 34(18.9)
Review of basic research with animals as subjects 9(0.5)
Issuing of a committee approval certificate for the editorial board of an 
academic journal
19(10.6)
Policy making 99(55.5)
Consultation 58(32.2)
Education 30(16.7)BMC Medical Ethics 2007, 8:8 http://www.biomedcentral.com/1472-6939/8/8
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